Former FDA Chief Information Officer Joins Precision for Medicine

Eric Perakslis to serve as Senior Advisor and joins leadership team for growing bioinformatics and health information technology practice

News provided by

Precision for Medicine, Inc.

Aug 13, 2013, 09:00 ET

BETHESDA, Md., Aug. 13, 2013 /PRNewswire/ -- Precision for Medicine, Inc., ("Precision"), the specialized scientific services company formed in 2012 to support next generation medical products, today announced the appointment of Eric Perakslis, PhD to the role of Senior Advisor, Bioinformatics and Information Technology. Dr. Perakslis will provide strategic and scientific guidance to the Precision leadership team in the development, acquisition, and execution of products and services in the rapidly evolving field of bioinformatics and health information technology. The addition of Dr. Perakslis expands and enhances Precision's ability to support life science innovators in the development and commercialization of next generation medicines.

In addition to his role at Precision, Dr. Perakslis serves as the Executive Director of the Center for Biomedical Informatics and the Francis A. Countway Library of Medicine at Harvard Medical School. Prior to joining Harvard, Dr. Perakslis held the position of Chief Information Officer and Chief Scientist of Informatics at the Food and Drug Administration. Dr. Perakslis joined the FDA after a distinguished career in executive leadership at Johnson & Johnson, where his positions included Chief Information Officer, Director of Research Information Technology, and Director of Drug Discovery Research.

"Dr. Perakslis is an important addition to the Precision for Medicine leadership team," said Mark Clein, President. "Informatics and information technology are at the center of the advances taking place in drug development and Dr. Perakslis brings a rare combination of insight, experience, and success from his leadership experience in industry, government, and academia."

"The pressure to find a better and lower cost path for drug development is intensifying and the requirements of health reform only increase the need for specialized scientific expertise and health information technology," said Dr. Perakslis. "I look forward to working with the Precision for Medicine team to identify and develop innovative approaches, technologies, and partners to address these challenges and support next generation 'precision medicine'. "

About Precision for Medicine
Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD with offices in Frederick, MD and Cambridge, MA. For more information about Precision, visit www.precisionformedicine.com.

SOURCE Precision for Medicine, Inc.